Human factors issues in ventricular assist device recipients and their family caregivers.

Ultimately, for ventricular assist devices (VADs) to be acceptable as permanent alternatives to heart transplantation, patients' and their families' satisfaction with specific features and risks of VADs must be addressed. Of 42 eligible patients who received VADs between February of 1996 and December of 1998, we interviewed 37 patients (17 Novacor, 18 Thoratec, 2 with both devices) and 20 of their primary family caregivers about device related concerns and reactions. Demographic and health related correlates of respondents' concerns were examined. Eleven patients discharged from the hospital with the VAD in place were then reinterviewed 1 month after discharge. At baseline, patients' general perceptions of the VAD were positive, although 22-52% reported specific concerns, including most often worry about infection (52%), difficulty sleeping due to the position of the driveline (52%), pain at the driveline exit site (46%), worry about device malfunction (40%), and being bothered during the day by device noise (32%). The prevalence of most concerns rose with duration of VAD support. Caregivers' perceptions did not differ significantly from patients' perceptions. Outpatients were somewhat more concerned than inpatients about device noise and risk of stroke, but were markedly less concerned about infection. Across all patients, higher levels of device related concerns were correlated with more physical functional limitations and more psychological distress, and reduced quality of life. Demographic characteristics and device type were not uniformly related to device concerns.

[1]  B. Griffith,et al.  Quality of life outcomes in left ventricular assist system inpatients and outpatients. , 1999, ASAIO journal.

[2]  T. Myers,et al.  Extended cardiac support with a portable left ventricular assist system in the home. , 1996, ASAIO journal.

[3]  M. Wiklund,et al.  Incorporating human factors into the design of medical devices. , 1998, JAMA.

[4]  S. Murali,et al.  Mechanical circulatory support with the Novacor LVAS: world-wide clinical results. , 1999, The Thoracic and cardiovascular surgeon.

[5]  B. Griffith,et al.  Life Quality in the Era of Bridging to Cardiac Transplantation: Bridge Patients in an Outpatient Setting , 1993, ASAIO journal.

[6]  O. Frazier Outpatient LVAD: its time has arrived. , 1994, The Annals of thoracic surgery.

[7]  M C Oz,et al.  Implantable left ventricular assist devices. , 1998, The New England journal of medicine.

[8]  F. Keefe,et al.  Sampling of empirically supported psychological treatments from health psychology: smoking, chronic pain, cancer, and bulimia nervosa. , 1998, Journal of consulting and clinical psychology.

[9]  S. Kasper,et al.  Side effects, dropouts from treatment and cost consequences , 1998, International clinical psychopharmacology.

[10]  Burlington Db Human factors and the FDA's goals: improved medical device design. , 1996 .

[11]  Lora E. Burke,et al.  Compliance with cardiovascular disease prevention strategies: A review of the research , 1997, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[12]  P M Portner,et al.  Protocol for releasing Novacor left ventricular assist system patients out-of-hospital. , 1995, ASAIO journal.

[13]  E. Ringelstein,et al.  Cerebral and systemic embolization during left ventricular support with the Novacor N100 device. , 1998, The Annals of thoracic surgery.

[14]  A. Kales,et al.  Sleep and its disorders. , 1999, Annual review of medicine.

[15]  S. Weyerer,et al.  Prevalence and treatment of insomnia in the community: results from the Upper Bavarian Field Study. , 1991, Sleep.

[16]  M C Oz,et al.  Potential of left ventricular assist devices as outpatient therapy while awaiting transplantation. , 1994, The Annals of thoracic surgery.

[17]  C. Morin,et al.  Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. , 1999, JAMA.

[18]  T. Myers,et al.  Use of a left ventricular assist device in an outpatient setting. , 1994, ASAIO journal.

[19]  D. McGiffin,et al.  Infections during extended circulatory support: University of Alabama at Birmingham experience 1989 to 1994. , 1996, The Annals of thoracic surgery.

[20]  O. Howard Frazier,et al.  Bethesda Conference: conference for the design of clinical trials to study circulatory support devices for chronic heart failure. , 1998, The Annals of thoracic surgery.

[21]  J. Bench,et al.  Managing tinnitus: a comparison of different approaches to tinnitus management training. , 1997, British journal of audiology.

[22]  L. Pearlin,et al.  The structure of coping. , 1978, Journal of health and social behavior.

[23]  A. Mcguire,et al.  The direct costs to the NHS of discontinuing and switching prescriptions for hypertension , 1998, Journal of Human Hypertension.

[24]  B. Griffith,et al.  Chronic mechanical circulatory support: rehabilitation, low morbidity, and superior survival. , 1994, The Annals of thoracic surgery.

[25]  Militello Lg Learning to think like a user: using cognitive task analysis to meet today's health care design challenges. , 1998 .

[26]  A. Jette,et al.  Evaluation of an Implantable ventricular Assist System for Humans With Chronic Refractory Heart Failure. Measuring Quality of Life , 1995, ASAIO journal.

[27]  L. Bradley,et al.  Psychological and behavioral approaches to pain management for patients with rheumatic disease. , 1999, Rheumatic diseases clinics of North America.

[28]  M. Bergner,et al.  The Sickness Impact Profile: Development and Final Revision of a Health Status Measure , 1981, Medical care.